Patents by Inventor Mikkel Bo Hansen

Mikkel Bo Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10660597
    Abstract: The present invention relates to a method for estimating perfusion indices (PI) in a mammal (200), e.g. a human. Data (DAT, DAT?) representative of a contrast agent concentration as a function of time of an injected contrast agent is obtained from a medical imaging system (100). Perfusion indices (PI) are found by applying a parametric model (PM) for capillary transit time distributions as a function of time, and a minorize-maximization (MM) type procedure, such as an expectation-maximization (EM) type procedure, with regularization. The minorize-maximization type procedure has an exact analytical expression for the variance of an observation error of the contrast agent (C?) in a non-linear observation model for the contrast agent concentration used in the maximization step. Clinical tests performed for 7 patients show improved MTT mapping as compared to singular value decomposition (SVD), and reduced sensitivity to delay.
    Type: Grant
    Filed: September 19, 2014
    Date of Patent: May 26, 2020
    Assignee: Aarhus Universitet
    Inventors: Kim Mouridsen, Mikkel Bo Hansen, Irene Klærke Mikkelsen, Susanne Lise Bekke, Birgitte Fuglsang Kjølby
  • Patent number: 9679378
    Abstract: The present invention relates to a method for generating a risk map indicating predicted voxel-by-voxel probability of tissue infarction for a set of voxels, the method comprising the steps of, receiving for each voxel a first value (x) corresponding to a set of tissue marker values and generating the risk map, using a statistical model based on data from a group of subjects, and a stochastic variable, wherein the statistical model also comprises a second value (zi), being based on the stochastic variable, such as the second value modelling non-measured values. The invention may be seen as advantageous since it acknowledges subject variability in probability of tissue infarction on a voxel-by-voxel basis by taking non-measured values into account, which in turn may enable providing more reliable estimates of probability of infarction.
    Type: Grant
    Filed: September 19, 2013
    Date of Patent: June 13, 2017
    Assignee: Aarhus Universitet
    Inventors: Kim Mouridsen, Kartheeban Nagenthiraja, Mikkel Bo Hansen
  • Publication number: 20160228085
    Abstract: The present invention relates to a method for estimating perfusion indices (PI) in a mammal (200), e.g. a human. Data (DAT, DAT?) representative of a contrast agent concentration as a function of time of an injected contrast agent is obtained from a medical imaging system (100). Perfusion indices(PI) are found by applying a parametric model (PM) for capillary transit time distributions as a function of time, and a minorize-maximization (MM) type procedure, such as an expectation-maximization (EM) type procedure, with regularization. The minorize-maximization type procedure has an exact analytical expression for the variance of an observation error of the contrast agent (C?) in a non-linear observation model for the contrast agent concentration used in the maximization step. Clinical tests performed for 7 patients show improved MTT mapping as compared to singular value decomposition (SVD), and reduced sensitivity to delay.
    Type: Application
    Filed: September 19, 2014
    Publication date: August 11, 2016
    Inventors: Kim MOURIDSEN, Mikkel Bo HANSEN, Irene Klærke MIKKELSEN, Susanne Lise BEKKE, Birgitte Fuglsang KJOLBY
  • Publication number: 20150228076
    Abstract: The present invention relates to a method for generating a risk map indicating predicted voxel-by-voxel probability of tissue infarction for a set of voxels, the method comprising the steps of, receiving for each voxel a first value (x) corresponding to a set of tissue marker values and generating the risk map, using a statistical model based on data from a group of subjects, and a stochastic variable, wherein the statistical model also comprises a second value (zi), being based on the stochastic variable, such as the second value modelling non-measured values. The invention may be seen as advantageous since it acknowledges subject variability in probability of tissue infarction on a voxel-by-voxel basis by taking non-measured values into account, which in turn may enable providing more reliable estimates of probability of infarction.
    Type: Application
    Filed: September 19, 2013
    Publication date: August 13, 2015
    Inventors: Kim Mouridsen, Kartheeban Nagenthiraja, Mikkel Bo Hansen